Accelera Innovations

Accelera Innovations SG&A Expenses

The Selling, General & Administrative Expenses of Accelera Innovations (ACNV) as of Nov 4, 2026 is 1.90 M USD. In the previous year, Selling, General & Administrative Expenses was 14.89 M USD — a change of -87.24% (lower).

SG&A Expenses

1.90 MUSD

YoY

-87.24%

Last updated:

Selling, General & Administrative Expenses of Accelera Innovations is 2016 1.90 M USD. Selling, General & Administrative Expenses of Accelera Innovations was 2015 14.89 M USD. It decreases by -87.24% lower compared to the previous year.

The Accelera Innovations SG&A Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

SG&A Expenses
Date
SG&A Expenses
Jan 1, 2014
32.81 M USD
Jan 1, 2015
14.89 M USD
Jan 1, 2016
1.90 M USD
The Accelera Innovations SG&A Expenses history
YEARSG&A ExpensesYoY
1.90 MUSD-87.24%
14.89 MUSD-54.61%
32.81 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Accelera Innovations Stock analysis

What does Accelera Innovations do? Accelera Innovations, Inc. generates revenue through its subsidiary SCI Home Health, Inc., operating as Advance Lifecare Home Health, which provides personal care services to patients in the Chicago, Illinois area. The company focuses on acquiring businesses in the post-acute care patient services and information technology services sectors, with SCI Home Health representing its primary healthcare service offering. Revenue is derived from healthcare service contracts within the post-acute care segment, targeting patients requiring ongoing care after hospitalization. The company's business model centers on strategic acquisitions within the healthcare services industry, specifically targeting post-acute care providers and technology service firms. SCI Home Health, Inc. serves as the operational vehicle for delivering personal care services, while the company's acquisition strategy aims to expand its presence in the healthcare sector through targeted investments in complementary businesses. The firm's revenue streams are primarily tied to the delivery of home health services under the Advance Lifecare Home Health brand in the Chicago metropolitan area. Accelera Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accelera Innovations stock

Selling, General & Administrative Expenses of Accelera Innovations is 1.90 M USD in 2016.

Selling, General & Administrative Expenses of Accelera Innovations changed from 14.89 M USD to 1.90 M USD, representing a -87.24% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Selling, General & Administrative Expenses Accelera Innovations since 2006 – with annual values, charts, and detailed analysis.

SG&A expenses include all non-production costs such as salaries, marketing, rent, and administrative overhead. They are a key component of operating expenses.

Selling, General & Administrative Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Selling, General & Administrative Expenses's Accelera Innovations historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Accelera Innovations

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Accelera Innovations